Clinical application of transnasal endotracheal intubation guided by oropharyngeal airway combined with bronchofiberscope

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050051

Enrollment

Unknown

Registered

2021-08-16

Start date

2021-08-16

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

OPA+FOB group:Oropharyngeal airway combined with bronchoscopy guided nasotracheal intubation

FOB group:Bronchoscopy-guided nasotracheal intubation

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists (ASA) performance status I–II; 2. Aged > 18 and < 60 years.

Exclusion criteria

Exclusion criteria: 1. Cervical instability, nasal bone fracture, nasal septum deviation, skull base fracture; 2. BMI>=30kg/m^2; 3. Preoperative Mallampati grade >= grade III, history of difficult tracheal intubation; 4. Respiratory tract inflammation, nasal congestion, foreign bodies in the upper respiratory tract, tumors, polyps, laryngeal injury, high risk of reflux aspiration, and chronic renal failure requiring dialysis for obstructive sleep ventilation disorders; 5. Coagulation disorders; 6. Those who are expected to have difficulty in mask ventilation due to severe maxillofacial deformity or intraoral mass; 7. Patients who refuse or cannot provide informed consent.

Design outcomes

Primary

Measure	Time frame
Intubation time;	—

Countries

China

Contacts

Public ContactLi Xiaoxia

Chongqing Yongchuan District People's Hospital

1072700307@qq.com+86 13368380465

Outcome results